ScholarIQanswers from OpenAlex & ORCID
Ronglai Shen
ResearcherPublications, citations & collaboration network
Ronglai Shen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ronglai Shen have?
ScholarIQindexed works
Ronglai Shen has 312 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ronglai Shen have?
ScholarIQcitation count
Ronglai Shen has 40,529 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ronglai Shen?
ScholarIQh-index
Ronglai Shen has an h-index of 69 in OpenAlex.
What is the i10-index of Ronglai Shen?
ScholarIQi10-index
Ronglai Shen has an i10-index of 118 in OpenAlex.
What is the ORCID of Ronglai Shen?
ScholarIQorcid
The ORCID for Ronglai Shen is on the source record.
What is the OpenAlex record for Ronglai Shen?
ScholarIQopenalex
The OpenAlex for Ronglai Shen is on the source record.
What are the most-cited papers on Ronglai Shen?
ScholarIQmost cited works
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Pedram Razavi, Bob T. Li, David N. Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino de Bruijn, Chenlu Hou, Oliver Venn, Raymond S. Lim, Aseem Anand, Tara Maddala, Sante Gnerre, Ravi Vijaya Satya, Qin‐Wen Liu, Ling Shen, Nicholas Eattock, Jeanne Yue, Alexander W. Blocker, Mark Lee, Amy J. Sehnert, Hui Xu, Megan P. Hall, Angie Santiago-Zayas, William Novotny, James M. Isbell, Valerie W. Rusch, George Plitas, Alexandra S. Heerdt, Marc Ladanyi, David M. Hyman, David R. Jones, Monica Morrow, Gregory J. Riely, Howard I. Scher, Charles M. Rudin, Mark E. Robson, Luis A. Díaz, David B. Solit, Alexander M. Aravanis, Jorge S. Reis‐Filho
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes
Michael Offin, Joseph M. Chan, Megan Tenet, Hira Rizvi, Ronglai Shen, Gregory J. Riely, Natasha Rekhtman, Yahya Daneshbod, Àlvaro Quintanal-Villalonga, Alexander Penson, Matthew D. Hellmann, Maria E. Arcila, Marc Ladanyi, Dana Pe’er, Mark G. Kris, Charles M. Rudin, Helena A. Yu
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
Bob T. Li, Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai, Sophie Shifman, Hai‐Yan Tu, Mackenzie L. Myers, Chong‐Rui Xu, Marissa S. Mattar, Inna Khodos, Megan Little, Besnik Qeriqi, Gregory Weitsman, Clare J. Wilhem, Alshad S. Lalani, Irmina Diala, Rachel A. Freedman, Nancy U. Lin, David B. Solit, Michael F. Berger, Paul R. Barber, Tony Ng, Michael Offin, James M. Isbell, David R. Jones, Helena A. Yu, Sheeno Thyparambil, Wei‐Li Liao, Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti